Abstract
Nonalcoholic fatty liver disease influences 25% of the people and can keep going to cirrhosis with insufficient treatment options. Therefore, early diagnosis of nonalcoholic fatty liver disease is very important. The study aims to measure the serum concentrations of Afamin (AFM) in non-alcoholic fatty liver cases (NAFLD) and to determine their link with the stage of the disease. The study comprised (60) cases suffering from non-alcoholic fatty liver disease in Kirkuk governorate, their ages varied between (30-75), The control group comprised (30) healthy individuals who did not suffer from non-alcoholic fatty liver disease (NAFLD).The concentration of Afamin in the blood was measured, as well as some biochemical indicators were calculated such as (Alanine aminotransferase ALT, Aspartate aminotransferase AST, Alkaline transferase ALP, Gamma-glutamyl transferase GGT). The concentration of Afamin was seen to be significantly higher in cases with non-alcoholic fatty liver disease at a probability level (p≤ 0.001) as compared to the control group. Through these results, it was concluded that the Afamin hormone can be handled as an index of non-alcoholic fatty liver disease (NAFLD).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Chemical and Biological Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
